Hakutulokset - G. Verhoest

  • Näytetään 1 - 13 yhteensä 13 tuloksesta
Tarkenna hakua
  1. 1
    The use of a ureteral access sheath does not improve stone-free rate after ureteroscopy for upper urinary tract stones

    The use of a ureteral access sheath does not improve stone-free rate after ureteroscopy for upper urinary tract stones Tekijä G. Berquet, Paul Prunel, G. Verhoest, Romain Mathiéu, Karim Bensalah

    Julkaistu 2013
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Impact of ischaemia time on renal function after partial nephrectomy: a systematic review

    Impact of ischaemia time on renal function after partial nephrectomy: a systematic review Tekijä Xavier Rod, B. Peyronnet, Thomas Seisen, Benjamin Pradère, Florie Gomez, G. Verhoest, Christophe Vaessen, Alexandre de la Taille, Karim Bensalah, Morgan Rouprêt

    Julkaistu 2016
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Predictive factors of recurrence and survival of upper tract urothelial carcinomas

    Predictive factors of recurrence and survival of upper tract urothelial carcinomas Tekijä G. Verhoest, Shahrokh F. Shariat, Thomas Chromecki, Jay D. Raman, Vitaly Margulis, Giacomo Novara, Christian Seitz, Mesut Remzi, Morgan Rouprêt, Douglas S. Scherr, Karim Bensalah

    Julkaistu 2011
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma

    Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma Tekijä Anthony Saroufim, Yosra Messai, Meriem Hasmim, Nathalie Rioux, Roberto Iacovelli, G. Verhoest, Karim Bensalah, J-J Patard, Laurence Albigès, Bruno Azzarone, Bernard Escudier, Salem Chouaı̈b

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma

    Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma Tekijä Solène‐Florence Kammerer‐Jacquet, Antoine Deleuze, Judikaël Saout, Romain Mathiéu, Brigitte Laguerre, G. Verhoest, Frédéric Dugay, Marc‐Antoine Belaud‐Rotureau, Karim Bensalah, Nathalie Rioux‐Leclercq

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study

    All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study Tekijä Cécile Vigneau, Nolwenn Lorcy, Thibault Dolley‐Hitze, F. Jouan, Yannick Arlot‐Bonnemains, Brigitte Laguerre, G. Verhoest, J.M. Goujon, Marc‐Antoine Belaud‐Rotureau, N. Costedoat‐Chalumeau

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Sunitinib Combined with Angiotensin-2 Type-1 Receptor Antagonists Induces More Necrosis: A Murine Xenograft Model of Renal Cell Carcinoma

    Sunitinib Combined with Angiotensin-2 Type-1 Receptor Antagonists Induces More Necrosis: A Murine Xenograft Model of Renal Cell Carcinoma Tekijä G. Verhoest, Thibault Dolley‐Hitze, Florence Jouan, Marc‐Antoine Belaud‐Rotureau, Emmanuel Oger, Audrey Lavenu, Karim Bensalah, Yannick Arlot‐Bonnemains, Nicolas Collet, N. Costedoat‐Chalumeau, Cécile Vigneau

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Immunotherapy in Renal Cell Carcinoma: The Future Is Now

    Immunotherapy in Renal Cell Carcinoma: The Future Is Now Tekijä Antoine Deleuze, Judikaël Saout, Frédéric Dugay, B. Peyronnet, Romain Mathiéu, G. Verhoest, Karim Bensalah, Laurence Crouzet, Brigitte Laguerre, Marc‐Antoine Belaud‐Rotureau, Nathalie Rioux‐Leclercq, Solène‐Florence Kammerer‐Jacquet

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Urinary Collecting System Invasion is an Independent Prognostic Factor of Organ Confined Renal Cell Carcinoma

    Urinary Collecting System Invasion is an Independent Prognostic Factor of Organ Confined Renal Cell Carcinoma Tekijä G. Verhoest, Р. Авакян, Karim Bensalah, Rodolphe Thuret, Vincenzo Ficarra, Walter Artibani, Jacques Tostain, F. Guillé, L. Cindolo, Alexandre de la Taille, Claude-Clément Abbou, Laurent Salomon, Nathalie Rioux‐Leclercq, Jean‐Jacques Patard

    Julkaistu 2009
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Independent association of PD‐L1 expression with noninactivated <i>VHL</i> clear cell renal cell carcinoma—A finding with therapeutic potential

    Independent association of PD‐L1 expression with noninactivated <i>VHL</i> clear cell renal cell carcinoma—A finding with therapeutic potential Tekijä Solène‐Florence Kammerer‐Jacquet, Laurence Crouzet, Angélique Brunot, Julien Dagher, A. Pladys, Julien Edeline, Brigitte Laguerre, B. Peyronnet, Romain Mathiéu, G. Verhoest, Jean‐Jacques Patard, Alexandra Lespagnol, Jean Mosser, Marc G. Denis, Yosra Messai, Sophie Gad, Salem Chouaı̈b, Marc‐Antoine Belaud‐Rotureau, Karim Bensalah, N. Costedoat‐Chalumeau

    Julkaistu 2016
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Patients with renal cell carcinoma nodal metastases can be accurately identified: External validation of a new nomogram

    Patients with renal cell carcinoma nodal metastases can be accurately identified: External validation of a new nomogram Tekijä Georg C. Hutterer, Jean‐Jacques Patard, Paul Perrotte, C. Ionescu, Alexandre de la Taille, Laurent Salomon, G. Verhoest, Jacques Tostain, Luca Cindolo, Vincenzo Ficarra, Walter Artibani, Luigi Schips, Richard Zigeuner, Peter F.A. Mulders, Antoine Valéri, Denis Chautard, Jean‐Luc Descotes, Jean‐Jacques Rambeaud, Arnaud Méjean, Pierre I. Karakiewicz

    Julkaistu 2007
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial

    Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial Tekijä Thierry Lebrét, Xavier Paolettí, G. Pignot, M. Roumiguié, Marc Colombel, L. Savareux, G. Verhoest, Laurent Guy, J. Rigaud, S. De Vergie, G. Poinas, S. Droupy, F. Kleinclauss, Monique Courtade‐Saïdi, Éric Piaton, C. Radulescu, N. Costedoat‐Chalumeau, Christine Kandel-Aznar, Karine Renaudin, Béatrix Cochand‐Priollet, Yves Allory, Sébastien Nivet, Morgan Rouprêt

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery

    The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery Tekijä Pierre Bigot, Jean‐Christophe Bernhard, Inderbir S. Gill, Nam Son Vuong, G. Verhoest, V. Flamand, B. Reix, Evren Süer, İlker Gökçe, Jean‐Baptiste Beauval, François Xavier Nouhaud, Masatoshi Eto, Eduard Baco, Toru Matsugasumi, Y. Chowaniec, J. Rigaud, C. Lenormand, Christian Pfister, Jean François Hetet, Guillaume Ploussard, Morgan Rouprêt, Priscilla Léon, A Bakri, S. Larré, X. Tillou, A. Doerfler, A. Descazeaud, N. Koutlidis, Alexandre Schneider, Philippe Sèbe, Alexandre Ingels, Abdel Rahmène Azzouzi, M. Soulié, Arnaud Méjean, Karim Bensalah, Jean‐Jacques Patard

    Julkaistu 2015
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: